Want to see AU:VIT full AI Analyst Report?

Cronos Australia Ltd. (VIT) Price & Analysis

18 Followers

VIT Stock Chart & Stats

AU$0.03

>-AU$0.01(-6.67%)

At close: Jul 27 4:00 PM EDT

AU$0.03

>-AU$0.01(-6.67%)

Day’s Range― - ―

52-Week RangeAU$0.02 - AU$0.07

Previous CloseN/A

Volume435.95K

Average Volume (3M)423.54K

Market Cap

AU$11.27M

Enterprise ValueAU$27.00M

Total Cash (Recent Filing)AU$5.35M

Total Debt (Recent Filing)AU$16.40M

Price to Earnings (P/E)―

Beta1.81

Next Earnings

Mar 02, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield10.53%

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding662,741,800

10 Day Avg. Volume490,274

30 Day Avg. Volume423,540

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)0.38

Price to Sales (P/S)0.13

P/FCF Ratio-76.41

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Regulated Cannabis FocusA focused position in medicinal cannabis gives Cronos Australia a clearly defined operating model and exposure to regulated demand. Production and supply capabilities within regulated markets can support compliance-based market access and provide a platform for continued business development.

Long-Term Revenue ExpansionRevenue expansion over the cycle indicates that the company has achieved meaningful scale in its target market despite the latest profitability setback. Continued top-line development can support operating leverage and provide a foundation for rebuilding earnings if margins stabilize.

Manageable LeverageA solid equity base and manageable leverage provide financial flexibility relative to a more highly stressed capital structure. This balance-sheet support can help Cronos Australia absorb operating volatility and preserve options to fund its regulated cannabis activities.

Bears Say

Profitability DeteriorationThe latest reversal from profit to loss, alongside a dramatic gross-profit decline, signals substantial margin pressure and earnings volatility. Unless profitability recovers, weaker earnings will constrain reinvestment capacity and make the business more dependent on balance-sheet resources.

Negative Cash GenerationNegative operating and free cash flow weaken the company’s ability to fund operations and growth internally. The reversal from several years of strong cash generation raises concern that underlying cash earnings are not currently durable, increasing the potential need for external funding.

Weaker Capital CushionHigher debt combined with declining equity reduces the balance-sheet cushion compared with the prior year, even though leverage remains manageable overall. This weaker capital position could limit flexibility if operating losses and negative cash flow persist across coming reporting periods.

Cronos Australia Ltd. News

Vitura Health posts strong Q1 and sharp EBITDA rebound as Three Horizon Plan targets profitability

Cronos Australia Ltd. ( ($AU:VIT) ) has issued an update. Vitura Health has reported an encouraging start to...

9d ago

VIT

Vitura Health installs permanent CFO as digital health and cannabis portfolio expands

Cronos Australia Ltd. ( ($AU:VIT) ) just unveiled an update. Vitura Health Limited has appointed James Frayne as...

23d ago

VIT

Vitura Health Sets 2026 AGM as Digital Health Portfolio Expands

Cronos Australia Ltd. ( ($AU:VIT) ) has provided an update. Vitura Health Limited has scheduled its 2026 Annual...

1M ago

VIT

Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook

Cronos Australia Ltd. ( ($AU:VIT) ) just unveiled an announcement. Vitura Health has disclosed a material setback for...

2M ago

VIT

Vitura Health pivots to disciplined growth after profit slump in FY2026

Cronos Australia Ltd. ( ($AU:VIT) ) has shared an update. Vitura reported FY2026 operating revenue of $131.2 million,...

2M ago

VIT

Vitura Health Files 2026 Corporate Governance Statement with ASX

Cronos Australia Ltd. ( ($AU:VIT) ) has shared an update. Vitura Health Limited has lodged its annual corporate...

2M ago

VIT

Vitura Health Slips to Loss as Cannabis Price Compression Squeezes Margins

Cronos Australia Ltd. ( ($AU:VIT) ) has issued an update. Vitura Health reported a consolidated loss after tax...

2M ago

VIT

Vitura Health Tightens Capital Structure as Rights and Options Lapse

Cronos Australia Ltd. ( ($AU:VIT) ) has provided an update. Vitura Health Limited has notified the market of...

3M ago

VIT

Vitura reshapes leadership team to cut costs and sharpen patient focus

Cronos Australia Ltd. ( ($AU:VIT) ) has issued an update. Vitura Health Limited has announced two senior appointments...

3M ago

VIT

Vitura Health Updates Corporate Address as Digital Health Network Expands

Cronos Australia Ltd. ( ($AU:VIT) ) has provided an announcement. Vitura Health Limited has updated its registered office...

4M ago

VIT

VIT FAQ

What was Cronos Australia Ltd.’s price range in the past 12 months?

Cronos Australia Ltd. lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.

What is Cronos Australia Ltd.’s market cap?

Cronos Australia Ltd.’s market cap is AU$11.27M.

When is Cronos Australia Ltd.’s upcoming earnings report date?

Cronos Australia Ltd.’s upcoming earnings report date is Mar 02, 2027 which is in 131 days.

How were Cronos Australia Ltd.’s earnings last quarter?

Cronos Australia Ltd. released its earnings results on Aug 25, 2026. The company reported -AU$0.005 earnings per share for the quarter.

Is Cronos Australia Ltd. overvalued?

According to Wall Street analysts Cronos Australia Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cronos Australia Ltd. pay dividends?

Cronos Australia Ltd. pays a Notavailable dividend of AU$0.002 which represents an annual dividend yield of 10.53%. See more information on Cronos Australia Ltd. dividends here

What is Cronos Australia Ltd.’s EPS estimate?

Cronos Australia Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cronos Australia Ltd. have?

Cronos Australia Ltd. has 662,741,800 shares outstanding.

What happened to Cronos Australia Ltd.’s price movement after its last earnings report?

Cronos Australia Ltd. reported an EPS of -AU$0.005 in its last earnings report. Following the earnings report the stock price went down -16.129%.

Which hedge fund is a major shareholder of Cronos Australia Ltd.?

Currently, no hedge funds are holding shares in AU:VIT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Cronos Australia Ltd. Stock Smart Score

Underperform

Blogger Sentiment

Bullish

AU:VIT Sentiment 100%
Sector Average 67%

Technicals

Fundamentals

Return on Equity

-9.80%

Trailing 12-Months

Asset Growth

1.65%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Cronos Australia Ltd.

Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.